Article

Anti-S-layer monoclonal antibodies impact Clostridioides difficile physiology

medRxiv · 2023 · Hunault, L.; Auria, E.; England, P.; Deschamps, J.; Briandet, R.; Kremer, V.; Iannascoli, B.; Vidal-Maison, L.; Guo, C.; Macdonald, L.; Pechine, S.; Deneve-Larrazet, C.; Dupuy, B.; Gorochov, G.; Bruhns, P.; Sterlin, D.

Key facts

Title Anti-S-layer monoclonal antibodies impact Clostridioides difficile physiology
First author Hunault, L.; Auria, E.; England, P.; Deschamps, J.; Briandet, R.; Kremer, V.; Iannascoli, B.; Vidal-Maison, L.; Guo, C.; Macdonald, L.; Pechine, S.; Deneve-Larrazet, C.; Dupuy, B.; Gorochov, G.; Bruhns, P.; Sterlin, D.
Journal medRxiv
Published Sep 21, 2023
DOI 10.1101/2023.09.21.558785
Devices mentioned 210111, BK110039, K103302, K822496
Product codes mentioned JIT, NDS, PCA, KIP, KIT, MVU, NJT, OOI

At a glance

  • 1–9 FDA submissions mentioned
  • 1–9 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature